Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

1p36 tumor suppression--a matter of dosage?

Henrich KO, Schwab M, Westermann F.

Cancer Res. 2012 Dec 1;72(23):6079-88. doi: 10.1158/0008-5472.CAN-12-2230. Epub 2012 Nov 20. Review.

3.

CHD5 is a tumor suppressor at human 1p36.

Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D, Bredel M, Vogel H, Mills AA.

Cell. 2007 Feb 9;128(3):459-75.

4.

The quest for the 1p36 tumor suppressor.

Bagchi A, Mills AA.

Cancer Res. 2008 Apr 15;68(8):2551-6. doi: 10.1158/0008-5472.CAN-07-2095. Review.

5.

Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakage-fusion-bridge cycles are involved in generating terminal deletions.

Ballif BC, Yu W, Shaw CA, Kashork CD, Shaffer LG.

Hum Mol Genet. 2003 Sep 1;12(17):2153-65. Epub 2003 Jul 15.

PMID:
12915474
6.

Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.

Okawa ER, Gotoh T, Manne J, Igarashi J, Fujita T, Silverman KA, Xhao H, Mosse YP, White PS, Brodeur GM.

Oncogene. 2008 Jan 31;27(6):803-10. Epub 2007 Jul 30.

PMID:
17667943
7.

Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.

White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M, Winter C, Gregory SG, Hogarty MD, Maris JM, Brodeur GM.

Oncogene. 2005 Apr 14;24(16):2684-94.

PMID:
15829979
8.

Molecular cloning and expression analysis of five novel genes in chromosome 1p36.

Onyango P, Lubyova B, Gardellin P, Kurzbauer R, Weith A.

Genomics. 1998 Jun 1;50(2):187-98.

PMID:
9653645
9.

Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers.

Nomoto S, Haruki N, Tatematsu Y, Konishi H, Mitsudomi T, Takahashi T, Takahashi T.

Genes Chromosomes Cancer. 2000 Jul;28(3):342-6.

PMID:
10862041
10.

Comprehensive analysis of chromosome 1p deletions in neuroblastoma.

Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM.

Med Pediatr Oncol. 2001 Jan;36(1):32-6.

PMID:
11464900
11.

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.

Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS.

Cancer Res. 2001 Jan 15;61(2):679-86.

12.

Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted.

Caron H, Spieker N, Godfried M, Veenstra M, van Sluis P, de Kraker J, Voûte P, Versteeg R.

Genes Chromosomes Cancer. 2001 Feb;30(2):168-74.

PMID:
11135433
13.

Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.

Hogarty MD, Liu X, Guo C, Thompson PM, Weiss MJ, White PS, Sulman EP, Brodeur GM, Maris JM.

Med Pediatr Oncol. 2000 Dec;35(6):512-5.

PMID:
11107105
14.

Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions.

Yu W, Ballif BC, Kashork CD, Heilstedt HA, Howard LA, Cai WW, White LD, Liu W, Beaudet AL, Bejjani BA, Shaw CA, Shaffer LG.

Hum Mol Genet. 2003 Sep 1;12(17):2145-52. Epub 2003 Jul 15.

PMID:
12915473
15.

Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?

Maris JM, Jensen J, Sulman EP, Beltinger CP, Allen C, Biegel JA, Brodeur GM, White PS.

Eur J Cancer. 1997 Oct;33(12):1991-6.

PMID:
9516840
16.

Contiguous ∼16 Mb 1p36 deletion: Dominant features of classical distal 1p36 monosomy with haplo-lethality.

Nicoulaz A, Rubi F, Lieder L, Wolf R, Goeggel-Simonetti B, Steinlin M, Wiest R, Bonel HM, Schaller A, Gallati S, Conrad B.

Am J Med Genet A. 2011 Aug;155A(8):1964-8. doi: 10.1002/ajmg.a.33210. Epub 2011 Jul 7.

PMID:
21739569
17.

Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.

Buckley PG, Jarbo C, Menzel U, Mathiesen T, Scott C, Gregory SG, Langford CF, Dumanski JP.

Cancer Res. 2005 Apr 1;65(7):2653-61.

18.

Complex structural rearrangement features suggesting chromoanagenesis mechanism in a case of 1p36 deletion syndrome.

Zanardo ÉA, Piazzon FB, Dutra RL, Dias AT, Montenegro MM, Novo-Filho GM, Costa TV, Nascimento AM, Kim CA, Kulikowski LD.

Mol Genet Genomics. 2014 Dec;289(6):1037-43. doi: 10.1007/s00438-014-0876-7. Epub 2014 Jul 2.

PMID:
24985706
19.

Detailed molecular analysis of 1p36 in neuroblastoma.

White PS, Thompson PM, Seifried BA, Sulman EP, Jensen SJ, Guo C, Maris JM, Hogarty MD, Allen C, Biegel JA, Matise TC, Gregory SG, Reynolds CP, Brodeur GM.

Med Pediatr Oncol. 2001 Jan;36(1):37-41.

PMID:
11464901
20.

Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.

Simoneau AR, Spruck CH 3rd, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA.

Cancer Res. 1996 Nov 1;56(21):5039-43.

Supplemental Content

Support Center